FIRST MANHATTAN CO. LLC. - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 96 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.3%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$14,000
-26.3%
6,4000.0%0.00%
Q2 2022$19,000
-77.4%
6,400
-48.4%
0.00%
Q1 2022$84,000
-18.4%
12,4000.0%0.00%
Q4 2021$103,000
+12.0%
12,4000.0%0.00%
Q3 2021$92,000
-64.8%
12,400
-67.7%
0.00%
-100.0%
Q2 2021$261,000
-33.8%
38,4000.0%0.00%
-50.0%
Q1 2021$394,000
+47.0%
38,4000.0%0.00%
+100.0%
Q4 2020$268,000
-25.3%
38,400
-12.7%
0.00%
-50.0%
Q3 2020$359,000
+18.5%
44,0000.0%0.00%0.0%
Q2 2020$303,000
+45.0%
44,0000.0%0.00%
+100.0%
Q1 2020$209,000
-45.6%
44,0000.0%0.00%
-50.0%
Q4 2019$384,000
+163.0%
44,0000.0%0.00%
+100.0%
Q3 2019$146,000
-60.1%
44,000
-40.5%
0.00%
-50.0%
Q2 2019$366,000
-20.1%
74,0000.0%0.00%
-33.3%
Q1 2019$458,000
+83.9%
74,0000.0%0.00%
+50.0%
Q4 2018$249,000
-48.2%
74,0000.0%0.00%
-33.3%
Q3 2018$481,000
-15.0%
74,0000.0%0.00%0.0%
Q2 2018$566,000
-67.5%
74,000
-5.1%
0.00%
-70.0%
Q1 2018$1,743,000
+75.4%
78,0000.0%0.01%
+100.0%
Q4 2017$994,000
+106.2%
78,000
+151.6%
0.01%
+66.7%
Q3 2017$482,00031,0000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders